South Korean device firm EOFlow Co., Ltd. worked with former Insulet Corporation employees and a contract manufacturer to copy Insulet’s Omnipod system, Insulet alleged in a lawsuit filed last week in Massachusetts federal court.
Insulet Lawsuit Alleges EOFlow Stole Diabetes Tech
The complaint says that EOFlow developed its EOPatch insulin delivery system with the help of former Insulet employees and Insulet’s contract manufacturer. Medtronic announced plans to acquire EOFlow in May, and US FDA clearance is on the horizon.
